Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 63 People Treated

<< Previous

Bullboard Posts

Next >>

Comment by Legit62on Feb 10, 2024 11:02am

216 Views

Post# 35873749

RE:RE:RE:63 People Treated

Covid hit and trying to get patients to fit profile of study was probably daunting, and probably lack of big funds didnt help, but what we need for BTD and Aa is already achieved, just waiting for paper and data to be approved by FDA, amazing what this company has done on a shoestring budget, congrats to them

<< Previous

Bullboard Posts

Next >>

E3 inches closer to Alberta's first lithium production plant